Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Every organ in our body contains a small number of adult stem cells that are specific to its niche. These cells act like a ...

The phase I clinical trials showed stem cell transplants for Parkinson’s disease appear to be safe and might restore dopamine-producing brain cells.

For decades, scientists assumed that neural stem cells (NSCs) only occur in the brain and spinal cord. A new international ...

Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might ...

Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...

Mitochondria play a crucial role in acquiring pluripotency and determining cell fate. The mitochondrial unfolded protein ...

Over the next decade, stem cell technology is expected to become even more refined. Treatments are anticipated to become increasingly personalized and tailored to individual needs. The vision ...

A team of researchers from more than ten laboratories in Europe, Asia and North America examined newly identified cells in mice called peripheral neural stem cells. These cells share important ...

This finding is particularly relevant for stem cell transplants, applied for the treatment of eg leukemia. Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight ...

Drug-Delivering Aptamers Target Leukemia Stem Cells for One-Two Knockout Punch Apr. 3, 2025 — Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the ...

Researchers can now generate brain cells from patients using stem cells, which gives them ... that of those without the disorder using hiPSC technology. Key changes, including abnormal neuronal ...